| Net Cash Provided by (Used in) Operating Activities |
$31,679,000 |
USD |
3.1% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$113,784,000 |
USD |
-113% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$51,448,000 |
USD |
92% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
30,784,118 |
shares |
-1.5% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$30,657,000 |
USD |
-833% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$161,963,000 |
USD |
14% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$34,382,000 |
USD |
0.07% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$124,715,000 |
USD |
284% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$2,575,000 |
USD |
93% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$699,235,000 |
USD |
-0.84% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$156,704,000 |
USD |
3.5% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$160,385,000 |
USD |
-2.5% |
Q3 2024 |
Q3 2024 |